Hanson Josh, Anstey Nicholas M, Bihari David, White Nicholas J, Day Nicholas P, Dondorp Arjen M
Crit Care. 2014 Nov 21;18(6):642. doi: 10.1186/s13054-014-0642-6.
Fluid resuscitation has long been considered a key intervention in the treatment of adults with severe falciparum malaria. Profound hypovolemia is common in these patients and has the potential to exacerbate the acidosis and acute kidney injury that are independent predictors of death. However, new microvascular imaging techniques have shown that disease severity correlates more strongly with obstruction of the microcirculation by parasitized erythrocytes--a process termed sequestration. Fluid loading has little effect on sequestration and increases the risk of complications, particularly pulmonary edema, a condition that can develop suddenly and unpredictably and that is frequently fatal in this population. Accordingly, even if a patient is clinically hypovolemic, if there is an adequate blood pressure and urine output, there may be little advantage in infusing intravenous fluid beyond a maintenance rate of 1 to 2 mL/kg per hour. The optimal agent for fluid resuscitation remains uncertain; significant anemia requires blood transfusion, but colloid solutions may be associated with harm and should be avoided. The preferred crystalloid is unclear, although the use of balanced solutions requires investigation. There are fewer data to guide the fluid management of severe vivax and knowlesi malaria, although a similar conservative strategy would appear prudent.
长期以来,液体复苏一直被视为治疗成人重症恶性疟的关键干预措施。这些患者常出现严重的血容量不足,并有加重酸中毒和急性肾损伤的可能,而酸中毒和急性肾损伤是死亡的独立预测因素。然而,新的微血管成像技术显示,疾病严重程度与被寄生红细胞阻塞微循环的相关性更强,这一过程称为滞留。液体输注对滞留影响不大,且会增加并发症风险,尤其是肺水肿,这种情况可能突然且不可预测地发生,在该人群中常常致命。因此,即使患者临床上存在血容量不足,但如果血压和尿量充足,以每小时1至2毫升/千克的维持速率输注静脉液体以外的液体可能并无太大益处。液体复苏的最佳药物仍不确定;严重贫血需要输血,但胶体溶液可能有害,应避免使用。尽管平衡溶液的使用需要研究,但首选的晶体溶液尚不清楚。关于重症间日疟和诺氏疟的液体管理的数据较少,不过采取类似的保守策略似乎是审慎的。